Superparamagnetic iron oxide nanoparticles change endothelial cell morphology and mechanics via reactive oxygen species formation

Journal of Biomedical Materials Research - Part A

Volumn 96 A, Issue 1, 2011, Pages 186-195

  Buyukhatipoglu, Kivilcim ^a   Clyne, Alisa Morss ^a,b  

^a Drexel University   (United States)

^b DREXEL UNIVERSITY   (United States)

Author keywords

AFM; cell morphology; endothelial cell; free radicals; nanoparticle; TEM

Indexed keywords

ACTIN CYTOSKELETON; AFM; CELL MORPHOLOGY; CELL VIABILITY; CELLULAR REACTIVE OXYGEN SPECIES; CYTOSKELETAL ORGANIZATION; FUNCTIONAL CHANGES; GENE DELIVERY; IN-VIVO; IRON OXIDE NANOPARTICLE; MAGNETIC HYPERTHERMIA; NANOPARTICLE COATINGS; NANOPARTICLE CONCENTRATIONS; REACTIVE OXYGEN SPECIES; SIDE EFFECT; STRESS FIBERS; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLES; SYSTEMIC ADMINISTRATION; TEM;

BLOOD VESSELS; CYTOLOGY; ELASTIC MODULI; FREE RADICALS; GENE THERAPY; GENE TRANSFER; IRON OXIDES; MAGNETIC RESONANCE IMAGING; MECHANICS; MEDICAL APPLICATIONS; MEDICAL IMAGING; MORPHOLOGY; NANOMAGNETICS; NANOPARTICLES; OXYGEN; PRESSURE EFFECTS; RESONANCE; SELF ASSEMBLY; SUPERPARAMAGNETISM;

ENDOTHELIAL CELLS;

ACTIN; CYTOSKELETON PROTEIN; NANOPARTICLE; REACTIVE OXYGEN METABOLITE; SCAVENGER; SUPERPARAMAGNETIC IRON OXIDE;

ANIMAL CELL; ARTICLE; BLOOD VESSEL; CELL DEATH; CELL ELONGATION; CELL FUNCTION; CELL STRUCTURE; CELL VIABILITY; CONTROLLED STUDY; CYTOSKELETON; ENDOTHELIUM CELL; NONHUMAN; STRESS FIBER; YOUNG MODULUS;

ACTINS; ANIMALS; BIOCOMPATIBLE MATERIALS; CELL SHAPE; CELLS, CULTURED; ENDOTHELIAL CELLS; FERRIC COMPOUNDS; HUMANS; MAGNETICS; MATERIALS TESTING; METAL NANOPARTICLES; MICROSCOPY, ATOMIC FORCE; REACTIVE OXYGEN SPECIES; SWINE;

EID: 78649579450     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.32972     Document Type: Article

References (55)

1. Gupta AK, Gupta M,. Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications. Biomaterials 2005; 26: 3995-4021.
2. Buyukhatipoglu K, Chang R, Sun W, Morss Clyne A,. Bioprinted nanoparticles for tissue engineering applications. Tissue Eng C Methods 2010; 16: 631-642.
3. Halavaara J, Tervahartiala P, Isoniemi H, Hockerstedt K,. Efficacy of sequential use of superparamagnetic iron oxide and gadolinium in liver MR imaging. Acta Radiol 2002; 43: 180-185.
4. Bonnemain B,. Superparamagnetic agents in magnetic resonance imaging: Physicochemical characteristics and clinical applications. A review. J Drug Target 1998; 6: 167-174.
5. Babincova M, Leszczynska D, Sourivong P, Babinec P,. Selective treatment of neoplastic cells using ferritin-mediated electromagnetic hyperthermia. Med Hypotheses 2000; 54: 177-179.
6. Mitsumori M, Hiraoka M, Shibata T, Okuno Y, Nagata Y, Nishimura Y, Abe M, Hasegawa M, Nagae H, Ebisawa Y,. Targeted hyperthermia using dextran magnetite complex: A new treatment modality for liver tumors. Hepato-Gastroenterol 1996; 43: 1431-1437.
7. Hilger I, Andra W, Hergt R, Hiergeist R, Schubert H, Kaiser WA,. Electromagnetic heating of breast tumors in interventional radiology: In vitro and in vivo studies in human cadavers and mice. Radiology 2001; 218: 570-575.
8. Jordan A, Wust P, Fahling H, John W, Hinz A, Felix R,. Inductive heating of ferrimagnetic particles and magnetic fluids-Physical evaluation of their potential for hyperthermia. Int J Hypertherm 1993; 9: 51-68.
9. Gupta AK, Curtis ASG,. Surface modified superparamagnetic nanoparticles for drug delivery: Interaction studies with human fibroblasts in culture. J Mater Sci Mater Med 2004; 15: 493-496.
10. Scherer F, Anton M, Schillinger U, Henkel J, Bergemann C, Kruger A, Gansbacher B, Plank C,. Magnetofection: Enhancing and targeting gene delivery by magnetic force in vitro and in vivo. Gene Ther 2002; 9: 102-109.
11. Dobson J,. Gene therapy progress and prospects: Magnetic nanoparticle-based gene delivery. Gene Ther 2006; 13: 283-287.
12. Buyukhatipoglu K, Miller TA, Clyne AM,. Flame synthesis and in vitro biocompatibility assessment of superparamagnetic iron oxide nanoparticles: Cellular uptake, toxicity, and proliferation studies. J Nanosci Nanotechnol 2009; 9: 6834-6843.
13. Nel A, Xia T, Madler L, Li N,. Toxic potential of materials at the nanolevel. Science 2006; 311: 622-627.
14. Risom L, Moller P, Loft S,. Oxidative stress-induced DNA damage by particulate air pollution. Mutat Res 2005; 592: 119-137.
15. Li N, Sioutas C, Cho A, Schmitz D, Misra C, Sempf J, Wang M, Oberley T, Froines J, Nel A,. Ultrafine particulate pollutants induce oxidative stress and mitochondrial damage. Environ Health Perspect 2003; 111: 455-460.
16. Sioutas C, Delfino RJ, Singh M,. Exposure assessment for atmospheric ultrafine particles (UFPs) and implications in epidemiologic research. Environ Health Perspect 2005; 113: 947-955.
17. Lin WS, Xu Y, Huang CC, Ma YF, Shannon KB, Chen DR, Huang YW,. Toxicity of nano- and micro-sized ZnO particles in human lung epithelial cells. J Nanoparticle Res 2009; 11: 25-39.
18. Bhattacharya K, Davoren M, Boertz J, Schins RP, Hoffmann E, Dopp E,. Titanium dioxide nanoparticles induce oxidative stress and DNA-adduct formation but not DNA-breakage in human lung cells. Part Fibre Toxicol 2009; 6: 17.
19. Donaldson K, Tran L, Jimenez LA, Duffin R, Newby DE, Mills N, MacNee W, Stone V,. Combustion-derived nanoparticles: A review of their toxicology following inhalation exposure. Part Fibre Toxicol 2005; 2: 10.
20. Lewis AB, Taylor MD, Roberts JR, Leonard SS, Shi X, Antonini JM,. Role of metal-induced reactive oxygen species generation in lung responses caused by residual oil fly ash. J Biosci 2003; 28: 13-18.
21. BeruBe K, Balharry D, Sexton K, Koshy L, Jones T,. Combustion-derived nanoparticles: Mechanisms of pulmonary toxicity. Clin Exp Pharmacol Physiol 2007; 34: 1044-1050.
22. Apopa PL, Qian Y, Shao R, Guo NL, Schwegler-Berry D, Pacurari M, Porter D, Shi X, Vallyathan V, Castranova V, Flynn DC,. Iron oxide nanoparticles induce human microvascular endothelial cell permeability through reactive oxygen species production and microtubule remodeling. Part Fibre Toxicol 2009; 6: 1.
23. Gupta AK, Curtis ASG,. Lactoferrin and ceruloplasmin derivatized superparamagnetic iron oxide nanoparticles for targeting cell surface receptors. Biomaterials 2004; 25: 3029-3040.
24. Gourlay CW, Carpp LN, Timpson P, Winder SJ, Ayscough KR,. A role for the actin cytoskeleton in cell death and aging in yeast. J Cell Biol 2004; 164: 803-809.
25. Gourlay CW, Ayscough KR,. The actin cytoskeleton: A key regulator of apoptosis and ageing? Nat Rev Mol Cell Biol 2005; 6: 583-589.
26. Boal D,. Mechanics of Cell. New York: Cambridge University Press; 2002.
27. Rotsch C, Radmacher M,. Drug-induced changes of cytoskeletal structure and mechanics in fibroblasts: An atomic force microscopy study. Biophys J 2000; 78: 520-535.
28. Elson EL,. Cellular mechanics as an indicator of cytoskeletal structure and function. Annu Rev Biophys Biophys Chem 1988; 17: 397-430.
29. Ohashi T, Sato M,. Remodeling of vascular endothelial cells exposed to fluid shear stress: Experimental and numerical approach. Fluid Dyn Res 2005; 37: 40-59.
30. Chiu JJ, Usami S, Chien S,. Vascular endothelial responses to altered shear stress: Pathologic implications for atherosclerosis. Ann Med 2009; 41: 19-28.
31. Wong MKK, Gotlieb AI,. In vitro reendothelialization of a single-cell wound-role of microfilament bundles in rapid lamellipodia-mediated wound closure. Lab Investig 1984; 51: 75-81.
32. Solon J, Levental I, Sengupta K, Georges PC, Janmey PA,. Fibroblast adaptation and stiffness matching to soft elastic substrates. Biophys J 2007; 93: 4453-4461.
33. Lu L, Oswald SJ, Ngu H, Yin FCP,. Mechanical properties of actin stress fibers in living cells. Biophys J 2008; 95: 6060-6071.
34. Callies C, Schon P, Liashkovich I, Stock C, Kusche-Vihrog K, Fels J, Strater AS, Oberleithner H,. Simultaneous mechanical stiffness and electrical potential measurements of living vascular endothelial cells using combined atomic force and epifluorescence microscopy. Nanotechnology 2009; 20: 174104.
35. Oberleithner H, Riethmuller C, Schillers H, MacGregor GA, de Wardener HE, Hausberg M,. Plasma sodium stiffens vascular endothelium and reduces nitric oxide release. Proc Natl Acad Sci USA 2007; 104: 16281-16286.
36. Gwinn MR, Vallyathan V,. Nanoparticles: Health effects-Pros and cons. Environ Health Perspect 2006; 114: 1818-1825.
37. Lum H, Roebuck KA,. Oxidant stress and endothelial cell dysfunction. Am J Physiol Cell Physiol 2001; 280: C719-C741.
38. Fink TL, Klepcyk PJ, Oette S, Gedeon CR, Hyatt SL, Kowalczyk TH, Moen RC, Cooper MJ,. Plasmid size up to 20 kbp does not limit effective in vivo lung gene transfer using compacted DNA nanoparticles. Gene Ther 2006; 13: 1048-1051.
39. Wilhelm C, Billotey C, Roger J, Pons JN, Bacri JC, Gazeau F,. Intracellular uptake of anionic superparamagnetic nanoparticles as a function of their surface coating. Biomaterials 2003; 24: 1001-1011.
40. Schmidt A, Hall MN,. Signaling to the actin cytoskeleton. Annu Rev Cell Dev Biol 1998; 14: 305-338.
41. Martindale JL, Holbrook NJ,. Cellular response to oxidative stress: Signaling for suicide and survival. J Cell Physiol 2002; 192: 1-15.
42. Droge W,. Free radicals in the physiological control of cell function. Physiol Rev 2002; 82: 47-95.
43. Kern JC, Kehrer JP,. Free radicals and apoptosis: Relationships with glutathione, thioredoxin and the bcl family of proteins. Front Biosci 2005; 10: 1727-1738.
44. Ku DN,. Blood flow in arteries. Annu Rev Fluid Mech 1997; 29: 399-434.
45. Mehta D, Malik AB,. Signaling mechanisms regulating endothelial permeability. Physiol Rev 2006; 86: 279-367.
46. Ding BS, Dziubla T, Shuvaev VV, Muro S, Muzykantov VR,. Advanced drug delivery systems that target the vascular endothelium. Mol Intervent 2006; 6: 98-112.
47. Zhang Y, Kohler N, Zhang M,. Surface modification of superparamagnetic magnetite nanoparticles and their intracellular uptake. Biomaterials 2002; 23: 1553-1561.
48. Gojova A, Guo B, Kota RS, Rutledge JC, Kennedy IM, Barakat AI,. Induction of inflammation in vascular endothelial cells by metal oxide nanoparticles: Effect of particle composition. Environ Health Perspect 2007; 115: 403-409.
49. Elias A, Tsourkas A,. Imaging circulating cells and lymphoid tissues with iron oxide nanoparticles. Hematol Am Soc Hematol Educ Program 2009: 720-726.
50. Corot C, Petry KG, Trivedi R, Saleh A, Jonkmanns C, Le Bas JF, Blezer E, Rausch M, Brochet B, Foster-Gareau P, Baleriaux D, Gaillard S, Dousset V,. Macrophage imaging in central nervous system and in carotid atherosclerotic plaque using ultrasmall superparamagnetic iron oxide in magnetic resonance imaging. Invest Radiol 2004; 39: 619-625.
51. Kooi ME, Cappendijk VC, Cleutjens KBJM, Kessels AGH, Kitslaar PJEHM, Borgers M, Frederik PM, Daemen MJAP, van Engelshoven JMA,. Accumulation of ultrasmall superparamagnetic particles of iron oxide in human atherosclerotic plaques can be detected by in vivo magnetic resonance imaging. Circulation 2003; 107: 2453-2458.
52. Zheng WW, Zhou KR, Chen ZW, Shen JZ, Chen CZ, Zhang SJ,. Characterization of focal hepatic lesions with SPIO-enhanced MRI. World J Gastroenterol 2002; 8: 82-86.
53. Engelhorn T, Doerfler A,. High-molar contrast agents for CNS application. Imaging Decisions MRI 2008; 11: 26-32.
54. Silver NC, Good CD, Barker GJ, MacManus DG, Thompson AJ, Moseley IF, McDonald WI, Miller DH,. Sensitivity of contrast enhanced MRI in multiple sclerosis. Effects of gadolinium dose, magnetization transfer contrast and delayed imaging. Brain 1997; 120: 1149-1161.
55. Nel AE, Madler L, Velegol D, Xia T, Hoek EMV, Somasundaran P, Klaessig F, Castranova V, Thompson M,. Understanding biophysicochemical interactions at the nano-bio interface. Nat Mater 2009; 8: 543-557.